Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance Data by Terai, Hideki, XX, Soejima, Kenzo, MD, PhD, Shimokawa, Asanao, XX, Horinouchi, Hidehito, XX, Shimizu, Junichi, XX, Hase, Tetsunari, XX, Kanemaru, Ryota, XX, Watanabe, Kana, XX, Ninomiya, Kiichiro, XX, Aragane, Naoko, XX, Yanagitani, Noriko, XX, Sakata, Yoshihiko, XX, Seike, Masahiro, XX, Fujimoto, Daichi, XX, Kasajima, Masashi, XX, Kubo, Akihito, XX, Kusumoto, Sojiro, XX, Oyamada, Yoshitaka, XX, Fujiwara, Keiichi, XX, Mori, Masahide, XX, Hashimoto, Midori, XX, Shingyoji, Masato, XX, Kodani, Masahiro, XX, Sakamoto, Jin, XX, Agatsuma, Toshihiko, XX, Kashiwabara, Kosuke, XX, Inomata, Minehiko, XX, Tachihara, Motoko, XX, Tanaka, Kazuhisa, XX, Hayashihara, Kenji, XX, Koyama, Nobuyuki, XX, Matsui, Kaoru, XX, Minato, Koichi, XX, Jingu, Daisuke, XX, Sakashita, Hiroyuki, XX, Hara, Satoshi, XX, Naito, Tomoyuki, XX, Okada, Asuka, XX, Tanahashi, Masayuki, XX, Sato, Yuki, XX, Asano, Koichiro, XX, Takeda, Takayuki, XX, Nakazawa, Kensuke, XX, Harada, Toshiyuki, XX, Shibata, Kazuhiko, XX, Kato, Tatsuo, XX, Miyaoka, Etsuo, XX, Yoshino, Ichiro, XX, Gemma, Akihiko, XX, Mitsudomi, Tetsuya, XX

Get full text